✦ LIBER ✦

P177 - Efficacy and safety of infliximab in patients with ulcerative colitis intolerant or resistant to conventional treatment

✍ Scribed by L. Evesque; J. Filippi; S.M. Schneider; X. Hébuterne

Book ID: 119636292
Publisher: Oxford University Press
Year: 2009
Tongue: English
Weight: 58 KB
Volume: 3
Category: Article
ISSN: 1873-9946
DOI: 10.1016/s1873-9946(09)60204-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of 6-thioguanine (6-

Safety and efficacy of 6-thioguanine (6-TG) in patients with ulcerative and indeterminate colitis intolerant or resistant to azathioprine and/or 6-mercaptopurine (Aza/6-MP)

✍ Teml, Alexander; Harrer, Marieluise; Schwab, Matthias; Dejaco, Clemens; Mantl, M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 231 KB

MAINTENANCE OF REMISSION WITH INFLIXIMAB

MAINTENANCE OF REMISSION WITH INFLIXIMAB IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS: EFFICACY AND SAFETY LONG-TERM TREATMENT

✍ S. Nasoni; A. Petrolati; N. Altavilla; Z. Rossi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Efficacy of methotrexate in Crohn’s dise

Efficacy of methotrexate in Crohn’s disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine

✍ M. WAHED; J. R. LOUIS-AUGUSTE; L. M. BAXTER; J. K. LIMDI; S. A. MCCARTNEY; J. O. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

72 P Short-term results of therapy with

72 P Short-term results of therapy with infliximab in patients with moderate active ulcerative colitis resistant to immunosupressive treatment

✍ G. Martorana; S. Peralta; A. Orlando; L. Oliva; A. Casà; M. Cottone 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 146 KB

PA.160 MAINTENANCE OF REMISSION WITH INF

PA.160 MAINTENANCE OF REMISSION WITH INFLIXIMAB IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS: EFFICACY AND SAFETY OF LONG-TERM TREATMENT

✍ A. Petrolati; S. Nasoni; N. Altavilla; R. Cipolla; P. Fenderico; G. Forlini; Z. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Open-label study of adalimumab in patien

Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab

✍ Waqqas Afif; Jonathan A. Leighton; Stephen B. Hanauer; Edward V. Loftus Jr; Will 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

## Background: The aim of this study was to assess the clinical benefit and tolerability of adalimumab, a fully human monoclonal antibody to tumor necrosis factor (TNF), in patients with ulcerative colitis (UC). Methods: Patients with active UC, including those who had lost response or developed